Document is current
Any future updates will be listed below
-
Authors
Tylawsky, Daniel E.
Kiguchi, Hiroto
Vaynshteyn, Jake
Gerwin, Jeffrey
Shah, Janki
Islam, Taseen
Boyer, Jacob A.
Boué, Daniel R.
Snuderl, Matija
Greenblatt, Matthew B.
Shamay, Yosi
Raju, G. Praveen https://orcid.org/0000-0003-1342-9132
Heller, Daniel A. https://orcid.org/0000-0002-6866-0000
- License Information
-
More Information
Article History
Received: 25 June 2021
Accepted: 18 January 2023
First Online: 2 March 2023
Competing interests
: D.A.H. is a cofounder and officer with equity interest of Selectin Therapeutics, Inc., Resident Diagnostics, Inc. and Lime Therapeutics, Inc., as well as a member of the scientific advisory board of Concarlo Therapeutics, Inc., Nanorobotics Inc. and Mediphage Bioceuticals, Inc. D.A.H. and Y.S. are inventors of a related patent, ‘Fucoidan nanogels and methods of their use and manufacture’, US patent no. 9,737,614 issued 7 July 2016 to MSKCC. G.P.R. is a cofounder and officer with equity interest of Selectin Therapeutics, Inc., as well as a member of the scientific and medical advisory board of Sapience Therapeutics, Inc. The remaining authors declare no competing interests.
